— Know what they know.
Not Investment Advice
BLCO.TO (TSX) is a cross-listing of BLCO (NYSE). Showing primary listing data.

BLCO

Bausch + Lomb Corporation
1W: -0.1% 1M: -13.2% 3M: -5.4% YTD: -3.4% 1Y: +0.6% 3Y: +0.2%
$16.02
+0.31 (+1.97%)
After Hours: $16.50 (+0.48, +3.03%)
NYSE · Healthcare · Medical - Instruments & Supplies · $5.7B · Alpha Radar Sell · Power 36
Smart Money Score
Moderate 50
Insider+$1.3M
Congress
ETF Holdings
Key Statistics
Market Cap$5.7B
52W Range10.45-18.915
Volume335,085
Avg Volume398,338
Beta0.58
Dividend
Analyst Ratings
7 Buy 8 Hold 1 Sell
Consensus Hold
Company Info
CEOBrenton L. Saunders
Employees13,500
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2022-05-06
Websitebausch.com
520 Applewood Crescent
Vaughan, ON L4K 4B4
CA
905 695 7700
About Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Recent Insider Trades

NameTypeSharesPriceDate
Eldessouky Sam P-Purchase 4,000 $17.13 2026-03-06
Eldessouky Sam A-Award 4,000 2026-03-06
SAUNDERS BRENT L P-Purchase 14,700 $17.14 2026-03-06
SAUNDERS BRENT L A-Award 14,700 2026-03-06
Bailey A Robert D P-Purchase 14,600 $17.15 2026-03-06

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms